Vitaccess Real MG Registry

Summary

Vitaccess Real MG (VRMG) is a patient registry designed to capture longitudinal observational data on myasthenia gravis (MG), its treatment, and impact on symptoms, daily activities, and quality of life (QoL). The duration of the registry is 10 years from launch, and approximately 600 patients will be recruited in the US and Europe with no defined upper limit. The registry will link relevant patient- and healthcare professional (HCP)-reported data with clinical data from medical records. Patients will be recruited at clinical sites in all participating countries. In the US only, patients can additionally be recruited via community neurologists or direct-to-patient recruitment.

Eligibility

Inclusion Criteria:

* Adult (age ≥18 years) with a clinically-confirmed diagnosis of myasthenia gravis (MG).
* Resident in one of the scope countries.
* Access to a smartphone/tablet/computer/laptop
* Willing and able to provide informed consent in their local language to take part in the study.

Exclusion Criteria:

* Participation in a clinical trial at the time of study enrolment.

Conditions2

Locations6 sites

Browse More Trials